Literature DB >> 3341320

Beneficial effect of blood transfusion in children with sickle cell chest syndrome.

A A Mallouh1, M Asha.   

Abstract

Reports in the 1970s suggested that acute chest syndrome (ACS) in children with sickle cell disease is usually due to bacterial infection. Studies in adults and more recently in children, however, showed that proved bacterial infection occurs in a minority of these patients and that vascular occlusion is the main pathologic process. In a retrospective study of 32 episodes of ACS in children, a definite bacterial infection was found in 3% (one patient), possible bacterial infection in 11% (four patients), and a possible mycoplasma in 13% (five patients). With the intent to dilute sickle cells, 23 patients received blood transfusion within 24 hours after hospital admission; all showed a dramatic clinical and roentgenographic improvement. Of the nine patients who did not receive a transfusion after hospital admission, the conditions of five patients deteriorated but improved after "late" transfusion; three patients showed slow improvement, and only one patient improved within 48 hours. From this we conclude that vascular occlusion might be the main process in ACS and that early blood transfusion may be valuable in shortening the course and decreasing mortality. The low hemoglobin value at presentation in our patients makes dilution of sickle cells possible by packed red blood cell transfusion rather than exchange transfusion.

Entities:  

Mesh:

Year:  1988        PMID: 3341320     DOI: 10.1001/archpedi.1988.02150020080034

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  9 in total

1.  Acute chest syndrome in children with sickle cell disease.

Authors:  H A Srair; J A Owa; H A Aman; M A Madan
Journal:  Indian J Pediatr       Date:  1995 Mar-Apr       Impact factor: 1.967

2.  Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.

Authors:  Scott T Miller; Hae-Young Kim; Debra L Weiner; Carrie G Wager; Dianne Gallagher; Lori A Styles; Carlton D Dampier; Susan D Roseff
Journal:  Transfusion       Date:  2012-07-13       Impact factor: 3.157

3.  Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE).

Authors:  Lori Styles; Carrie G Wager; Richard J Labotka; Kim Smith-Whitley; Alexis A Thompson; Peter A Lane; Lillian E C McMahon; Robin Miller; Susan D Roseff; Rathi V Iyer; Lewis L Hsu; Oswaldo L Castro; Kenneth I Ataga; Onyinye Onyekwere; Maureen Okam; Rita Bellevue; Scott T Miller
Journal:  Br J Haematol       Date:  2012-03-30       Impact factor: 6.998

Review 4.  Indications for transfusion in the management of sickle cell disease.

Authors:  Hyojeong Han; Lisa Hensch; Venée N Tubman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

5.  Improved survival in homozygous sickle cell disease: lessons from a cohort study.

Authors:  A Lee; P Thomas; L Cupidore; B Serjeant; G Serjeant
Journal:  BMJ       Date:  1995-12-16

Review 6.  Fatal pulmonary artery embolism in a sickle cell patient: case report and literature review.

Authors:  Dhanunjaya R Lakkireddy; Robert Patel; Krishnamohan Basarakodu; James Vacek
Journal:  J Thromb Thrombolysis       Date:  2002-08       Impact factor: 2.300

7.  Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease.

Authors:  John J Strouse; Clifford M Takemoto; Jeffrey R Keefer; Gregory J Kato; James F Casella
Journal:  Pediatr Blood Cancer       Date:  2008-05       Impact factor: 3.167

8.  Identification of Clinical and Laboratory Parameters Associated with the Development of Acute Chest Syndrome during Vaso-Occlusive Episodes in Children with Sickle Cell Disease: A Preliminary Step before Assessing Specific and Early Treatment Strategies.

Authors:  Fouad Madhi; Annie Kamdem; Camille Jung; Adele Carlier-Gonod; Sandra Biscardi; Jeremy Busca; Cecile Arnaud; Isabelle Hau; David Narbey; Ralph Epaud; Corinne Pondarre
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

9.  Outcomes of acute chest syndrome in adult patients with sickle cell disease: predictors of mortality.

Authors:  Veerajalandhar Allareddy; Aparna Roy; Min Kyeong Lee; Romesh P Nalliah; Sankeerth Rampa; Veerasathpurush Allareddy; Alexandre T Rotta
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.